Coherus Oncology (CHRS) Shares Outstanding (2013 - 2026)
Coherus Oncology's Shares Outstanding was 154.82 million in Q2 2026, up 33.4% from 116.08 million a year earlier and up 13.5% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Shares Outstanding (2013 - 2026) Analysis & Trends
For FY2025, Shares Outstanding at Coherus Oncology came in at 117.14 million, up 2.3% from FY2024.
- Shares Outstanding has now increased for 13 consecutive years, with a five-year compound annual growth rate of 10.4% (FY2020 to FY2025).
- In earlier years, Shares Outstanding was 114.55 million in FY2024 (+21.7%), 94.16 million in FY2023 (+21.3%), 77.63 million in FY2022 (+2.9%) and 75.45 million in FY2021 (+5.7%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding in data going back to Q3 2013.
- Compared with a year earlier, Shares Outstanding has increased for 15 straight quarters, with growth averaging 12.2% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding over five years was Q1 2024 (growth of 42.2%); the worst was Q3 2022 (a decline of 1.6%).
- Per Business Quant data, CHRS's Shares Outstanding in the three quarters before Q2 2026 was 136.4 million (Q1 2026), 117.14 million (Q4 2025) and 116.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 154.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154.82 Mn |
| Mar 31, 2026 | 136.40 Mn |
| Dec 31, 2025 | 117.14 Mn |
| Sep 30, 2025 | 116.23 Mn |
| Jun 30, 2025 | 116.08 Mn |
| Mar 31, 2025 | 115.86 Mn |
| Dec 31, 2024 | 114.55 Mn |
| Sep 30, 2024 | 115.21 Mn |
| Jun 30, 2024 | 114.82 Mn |
| Mar 31, 2024 | 112.75 Mn |
| Dec 31, 2023 | 94.16 Mn |
| Sep 30, 2023 | 97.74 Mn |
| Jun 30, 2023 | 87.27 Mn |
| Mar 31, 2023 | 79.27 Mn |
| Dec 31, 2022 | 77.63 Mn |
| Sep 30, 2022 | 77.75 Mn |
| Jun 30, 2022 | 77.55 Mn |
| Mar 31, 2022 | 77.25 Mn |
| Dec 31, 2021 | 75.45 Mn |
| Sep 30, 2021 | 79.01 Mn |
API Access
Coherus Oncology Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();